News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shanghai-Israel Fund Co-Leads $9 Million Funding Of Rapid Medical



7/19/2017 11:56:05 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
July 19, 2017 -- The Shanghai-Israel Investment Fund and BRM Group, an Israeli investment firm, co-led a $9 million Series B financing in Israel's Rapid Medical. Rapid is developing two neurovascular interventional devices: the Tigertriever Revascularization device used to remove stoke-causing clots, and the Comaneci Adjustable Remodeling Mesh, an external device used during embolization procedures. The B round will allow Rapid Medical to begin a US clinical trial of Tigertriever and European commercialization of both the Tigertriever and Comaneci devices.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES